Ruboxistaurin Completed Phase 3 Trials for Diabetes Mellitus / Diabetic Neuropathies Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00044421Treatment of Peripheral Neuropathy in Patients With Diabetes